The Firm recently represented JPMorgan Chase Bank, N.A., as administrative agent, in connection with AtriCure’s $125 million senior secured ABL revolving credit facility. Proceeds from the facility will be used for the working capital needs of AtriCure and its subsidiaries. The facility closed on January 5, 2024.
AtriCure, Inc. (NASDAQ: ATRC) is a leading innovator in treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain. Afib affects approximately 1% of the population in the United States. It is the most common cardiac arrhythmia, or irregular heartbeat, encountered in clinical practice.
The Simpson Thacher team included Brandan Still, Ron Havas, Tyler Wills and Adam Danciu (Banking and Credit); Marisa Geiger and Courtney Welshimer (Intellectual Property); Vanessa Burrows and Nawa Lodin (Healthcare); Ryan Stott and Sara Mazurek (Executive Compensation and Employee Benefits); Krista McManus and Timothy Gallagher (Real Estate); Michael Mann (Tax); and Jon Pall (Collateral).